Cellular uptake and efflux of palbociclib in vitro in single cell and spheroid models
(2019)
Journal Article
Jove, M., Spencer, J. A., Hubbard, M. E., Holden, E. C., O'Dea, R. D., Brook, B. S., Phillips, R. M., Smye, S. W., Loadman, P., & Twelves, C. J. (2019). Cellular uptake and efflux of palbociclib in vitro in single cell and spheroid models. Journal of Pharmacology and Experimental Therapeutics, 370(2), 242-251. https://doi.org/10.1124/jpet.119.256693
Adequate drug distribution through tumors is essential for treatment to be effective. Palbociclib is a cyclin-dependent kinase 4/6 inhibitor approved for use in patients with hormone receptor positive, human epidermal growth factor receptor 2 negativ... Read More about Cellular uptake and efflux of palbociclib in vitro in single cell and spheroid models.